数据链接：
官方服务：
资源简介：
IL28 Genotype analysis (112/130 patients).
应用场景：
创建时间：
2015-12-02
相关数据集
Rates of HCV RNA undetectability during treatment stratified by ITPA deficiency.
*No ITPA deficiency versus any ITPA deficiency.
NIAID Data Ecosystem50
Genetic Variation of the IL-28B Promoter Affecting Gene Expression
The current standard of care for the treatment of chronic hepatitis C is pegylated interferon-α (PEG-IFNα) and ribavirin (RBV). The treatment achieves a sustained viral clearance in only approximately
Figshare2016-01-18 更新10
Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy
Pegylated-interferon plus ribavirin (PEG-IFN/RBV) therapy is a current standard treatment for chronic hepatitis C. We previously reported that the viral sequence heterogeneity of part of NS5A, referre
Figshare2016-01-18 更新10
Clinical data of patients with acute hepatitis C
IFN = interferon-alpha; RBV = ribavirin; NR = non-responder to antiviral therapy; SR = sustained responder to antiviral therapy.
NIAID Data Ecosystem30
Average numbers of aa mutations within IRRDR[2a], ISDR/+C[2a] and IRRDR/N[2b] of HCV NS5A obtained form pre-treated sera of HCV-2a and -2b-infected patients with SVR, non-SVR, RVR and non-RVR.
*Mean ± S.D. Abbreviations: SVR, sustained virological response; RVR, rapid virological response; IRRDR[2a], interferon/ribavirin resistance-determining region of HCV-2a; ISDR/+C[2a], part of interfer
NIAID Data Ecosystem10
